Strengthening airway immunity could advance respiratory vaccines and therapies
Opioid use can become long-term following surgery
How the eyes could unlock personalised pain relief with virtual reality
Twenty-five years and thousands of learners: UHCW anaesthesia programme celebrates education milestone
Could staying active before surgery help prevent postoperative delirium?
  • HOME
  • NEWS
  • ARTICLES
    • COMPANY INTERVIEWS
    • PROMOTIONAL FEATURES
  • PRODUCT
  • DIRECTORY
  • EVENTS
    • JANUARY 2027
    • MARCH 2027
  • BOOK REVIEWS
  • ABOUT
    • EDITORIAL BOARD
    • CONTACT US
Journal of Anaesthesia Practice
  • HOME
  • NEWS
  • ARTICLES
    • COMPANY INTERVIEWS
    • PROMOTIONAL FEATURES
  • PRODUCT
  • DIRECTORY
  • EVENTS
    • JANUARY 2027
    • MARCH 2027
  • BOOK REVIEWS
  • ABOUT
    • EDITORIAL BOARD
    • CONTACT US

AlzeCure

Home / AlzeCure

30 January 2024

AlzeCure selects drug candidate and enters next phase of development against severe pain

AlzeCure Pharma AB, a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the...

Read More
17 December 2020

AlzeCure presents positive preclinical efficacy data for the TrkA-NAM pain project

AlzeCure Pharma, a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system,...

Read More
SUBSCRIBE

and receive all of the latest news via our weekly newsletter

"*" indicates required fields